- Home
- USAC vs AMED Comparison
USAC vs AMED Comparison
Compare USAC & AMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USAC
- AMED
- Stock Information
- Founded
- USAC 1998
- AMED 1982
- Country
- USAC United States
- AMED United States
- Employees
- USAC N/A
- AMED N/A
- Industry
- USAC Natural Gas Distribution
- AMED Medical/Nursing Services
- Sector
- USAC Utilities
- AMED Health Care
- Exchange
- USAC Nasdaq
- AMED Nasdaq
- Market Cap
- USAC N/A
- AMED 3.0B
- IPO Year
- USAC N/A
- AMED N/A
- Fundamental
- Price
- USAC $25.22
- AMED $91.76
- Analyst Decision
- USAC Hold
- AMED Hold
- Analyst Count
- USAC 4
- AMED 6
- Target Price
- USAC $26.00
- AMED $100.80
- AVG Volume (30 Days)
- USAC 314.4K
- AMED 337.5K
- Earning Date
- USAC 05-06-2025
- AMED 04-28-2025
- Dividend Yield
- USAC 8.43%
- AMED N/A
- EPS Growth
- USAC 260.00
- AMED N/A
- EPS
- USAC 0.72
- AMED 1.31
- Revenue
- USAC $950,449,000.00
- AMED $2,348,324,000.00
- Revenue This Year
- USAC $6.37
- AMED $6.54
- Revenue Next Year
- USAC $5.24
- AMED $5.32
- P/E Ratio
- USAC $35.03
- AMED $70.05
- Revenue Growth
- USAC 12.32
- AMED 5.00
- 52 Week Low
- USAC $21.06
- AMED $82.15
- 52 Week High
- USAC $30.10
- AMED $98.95
- Technical
- Relative Strength Index (RSI)
- USAC 49.01
- AMED 45.89
- Support Level
- USAC $21.72
- AMED $90.93
- Resistance Level
- USAC $24.43
- AMED $92.41
- Average True Range (ATR)
- USAC 1.34
- AMED 1.24
- MACD
- USAC 0.03
- AMED -0.07
- Stochastic Oscillator
- USAC 58.93
- AMED 45.82
About AMED Amedisys Inc
Amedisys Inc is a healthcare services company in the United States. The company brings healthcare to the home through the provision of home healthcare services, hospice services, and high acuity care segment. The Home Health Segment provides skilled nurses, therapists, and aids to patients' homes throughout the United States; the Hospice segment operates many centers designed to provide comfort and support for terminally ill patients; and the High acuity care segment can deliver the essential elements of inpatient hospital, SNF care, and palliative care to patients in their homes. A majority of the company's revenue is derived from the Home Health segment.